According to a recent LinkedIn post from Bright Uro, The Howard Center for Women’s Health has adopted the company’s Glean urodynamics solution. The post indicates this is the first gynecology practice in the U.S., and the first practice of any specialty in Georgia, to offer Glean.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn content cites comments from Dr. Drew Howard, who is described as planning to expand urodynamic services to all 12 locations in the group. The post suggests that Glean may enable more accessible and comfortable diagnostic care, potentially supporting higher procedure volumes and reinforcing Bright Uro’s value proposition in women’s health.
For investors, this early adoption by a multi-site gynecology provider could be viewed as a proof point for clinical interest in Glean within a sizable outpatient segment. If similar groups follow, Bright Uro may see a growing installed base that could drive recurring usage and strengthen its competitive position in the urodynamics and pelvic health technology market.